Cottage Street Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Buy
2,635
+595
+29% +$608K 1.22% 23
2026
Q1
$1.88M Buy
2,040
+200
+11% +$203K 0.81% 36
2025
Q4
$1.98M Sell
1,840
-900
-33% -$861K 0.84% 30
2025
Q3
$2.11M Buy
2,740
+2,201
+408% +$1.64M 0.9% 31
2025
Q2
$420K Buy
539
+6
+1% +$4.66K 0.22% 74
2025
Q1
$440K Buy
533
+13
+3% +$10.8K 0.22% 71
2024
Q4
$402K Buy
520
+34
+7% +$28.2K 0.21% 76
2024
Q3
$430K Buy
486
+5
+1% +$4.5K 0.23% 67
2024
Q2
$436K Sell
481
-5
-1% -$4K 0.26% 62
2024
Q1
$378K Sell
486
-1
-0.2% -$712 0.23% 66
2023
Q4
$283K Sell
487
-14
-3% -$8.17K 0.19% 71
2023
Q3
$269K Buy
501
+16
+3% +$8.24K 0.2% 71
2023
Q2
$227K Buy
+485
New +$203K 0.16% 78

Other funds holding LLY

Cottage Street Advisors's LLY Position: Q2 2026 in Review

Cottage Street Advisors increased its Eli Lilly (LLY) stake by 29% in Q2 2026, buying an estimated $608K and bringing the position to 2,635 shares worth $3.16M. The position accounts for 1.22% of the portfolio, ranked #23.

Cottage Street Advisors first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cottage Street Advisors held 2,635 shares of Eli Lilly worth $3.16M as of Q2 2026.
  • Cottage Street Advisors bought 595 Eli Lilly shares in Q2 2026, an estimated $608K.
  • Eli Lilly made up 1.22% of Cottage Street Advisors's portfolio in Q2 2026, its #23 holding.
  • Cottage Street Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cottage Street Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.